Epidemiology of cervix cancer in Brazil (2005-2015): study of mortality and hospital intervention rates

Keywords: Epidemiology, Uterine Cervical Cancer, Mortality, Hospitalization, Brazil

Abstract

Cervical neoplasia has high morbidity and mortality and is the main female gynecological neoplasia, but it is susceptible to early detection and cure. A major challenge for developing countries such as Brazil is the expansion of prevention programs, which becomes more effective when the epidemiology is known. The objective of this study was to conduct an epidemiological survey to evaluate the Brazilian panorama of this neoplasm. A temporal aggregate study was performed using the mortality and hospital admission rates for cervical neoplasia throughout the Brazilian territory during the years 2005 to 2015, data obtained through DATASUS and IBGE. During the years 2005 to 2015, there was a significant drop (p<0.05) in hospital admission rates in the 0-19, 20-39, 40-59, 60-79 years, with an average fall of 36 % and a death increase in the age group 20-39 years. The North region had a significant increase in death in the range ≥ 80 years, 140%, p<0.02. The mean mortality rate in Brazil was 5.14, with a 95% CI of 5.01 to 5.27. Cervical neoplasia is still present in Brazil, although mortality has a tendency to decrease, this tendency is unequally distributed in Brazil, with the north and northeast regions showing the highest rates. Better public policies are fundamental.

Downloads

Download data is not yet available.

References

Noveron NR, Nieves A, Rodriguez M, Betancourt A. Cervical Cancer Epidemiology [Internet]. Cidade do México; 2014 [cited 2018 Feb 20]. doi: 10.1007/978-1-4939-2013-6.

Frmovitz M. Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis [Internet]. UpToDate; 2017 [cited 2018 Feb 20]. Available from: www.uptodate.com

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30.

Machado LS, Pires Mc. Perfil Epidemiológico De Mulheres Com Papilomavírus Humano Que Utilizam O Serviço Público De Saúde. Rev Baiana Enferm. 2017; 31:1-9.

Newton CL, Mould TA. Invasive cervical cancer. Obstet Gynaecol Reprod Med. 2016; 27(1):7-13.

Krupinski J. Cervical Cancer: The Trending Topic in Oncology. J Vasc Med Surg. 2017; 5(3):6925.

Nour NM. Cervical Cancer: A Preventable Death. World Bank. 2009; 2(4):240-4.

Schiffman M, Solomon D. Cervical-Cancer Screening with Human Papillomavirus and Cytologic Cotesting. N Engl J Med. 2013; 369(24):2324-31.

Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah K V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002 Apr; 55(4):244-65.

Ci A, Ne M. Cervical Cancer: A Health Limiting Condition. Gynecol Obstet [Internet]. 2016 [cited 2018 Feb 20];6(5). Available from: https://www.omicsonline.org/open-access/cervical-cancer-a-health-limiting-condition-2161-0932- 1000378.php?aid=73905

Tsu V, Jeronimo J. Saving the World’s Women from Cervical Cancer. N Engl J Med. 2016; 363(1):1-3.

Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2017; 1-24.

Wheaton AG, Chapman DP, Presley-Cantrell LR, Croft JB, Roehler DR. Drowsy Driving — 19 States and the District of Columbia, 2009–2010. MMWR Morb Mortal Wkly Rep. 2013; 61(51):1033-7.

Básica. BM da SS de A à SD de A. Cadernos de Atenção Básica: Controle dos Cânceres do Colo do Útero e da Mama. 13th ed. Brasília; 2006.

Thuler LCS. Mortalidade por câncer do colo do útero no Brasil. Rev Bras Ginecol e Obs. 2008; 30:30-2.

Silva M, Fernadez J, Cardoso A, Silveira G, Arroyave L. Câncer De Colo De Útero: Análise Da Mortalidade Por Região Brasileira. News Lab. 2014.

Santana CK de souza L, Rezende SRF de, Manrique EJC. Tendência de Mortalidade por Câncer do Colo do Útero no Estado de Goiás no Período de 1989 a 2009. Rev Bras Cancerol. 2013; 59(1):9-16.

Barbosa IR, Souza DLB de, Bernal MM, Costa I do CC. Desigualdades regionais na mortalidade por câncer de colo de útero no Brasil: tendências e projeções até o ano 2030. Cien Saude Colet. 2016; 21(1):253-62.

Fernandes WC, Kimura M. Qualidade de vida relacionada à saúde de mulheres com câncer de colo uterino. Rev Latino-Am Enferm. 2010; 18(3):1-8.

Silva IN de CJAG da. Manual de Gestão da Qualidade para Laboratório de Citopatologia. Brasília: Ministério da Saúde; 2016.

Martins LFL, Thuler LCS, Valente JG. Cobertura do exame de Papanicolaou no Brasil e seus fatores determinantes: uma revisão sistemática da literatura. Rev Bras Ginecol Obstet. 2005; 27(8):485-92.

Inca. Programa Nacional de controle do câncer do colo de útero. Revista e ampliada do Programa Viva Mulher. Inca; 2011.

Volerman A, Cifu A. Cervical Cancer Screening. JAMAClinical Guidel Synopsis Cerv. 2014; 312(21):2279-80.

Alencar DL de, Marques AP de O, Leal MCC, Vieira J de CM. Fatores que interferem na sexualidade de idosos: uma revisão integrativa. Cien Saude Colet. 2014;19(8):3533-42.

Rozendo A da S, Alves JM. Sexualidade na terceira idade: tabus e realidade. Rev Kairós Gerontol. 2015;18(3):95-107.

Published
28-06-2019
How to Cite
Kuiava, V., & Chielle, E. (2019). Epidemiology of cervix cancer in Brazil (2005-2015): study of mortality and hospital intervention rates. Archives in Biosciences & Health, 1(1), 45-60. https://doi.org/10.18593/abh.17091
Section
Articles - Original research